Providing hematopoietic stem cell products from unrelated donors to the world : DKMS donor centers and DKMS Registry
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved..
Allogeneic hematopoietic stem cell (HSC) transplantation is a curative therapy for many severe blood diseases. As many patients have no suitable family donor, large unrelated donor registries and donor centers have been established in many countries, along with an international system for the provision of unrelated donor HSC products. As an essential part of this system, DKMS operates donor centers in 7 countries with a total of 12.2 million donors and over 114,000 donations so far, and a multinational donor registry. In 2022, DKMS donors contributed 57.5% of all cross-border donations worldwide. In this review, we describe the international system for the provision of unrelated donor HSC products as well as tasks and responsibilities of donor registries and donor centers. We also discuss relevant aspects of DKMS donor centers, namely donor file composition, matching and donation probabilities and actual donations, and the unique multinational approach of the DKMS Registry.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
---|---|
Enthalten in: |
Best practice & research. Clinical haematology - 37(2024), 1 vom: 15. März, Seite 101541 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Schmidt, Alexander H [VerfasserIn] |
---|
Links: |
---|
Themen: |
DKMS |
---|
Anmerkungen: |
Date Completed 18.03.2024 Date Revised 18.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.beha.2024.101541 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM369804422 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM369804422 | ||
003 | DE-627 | ||
005 | 20240318234920.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240316s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.beha.2024.101541 |2 doi | |
028 | 5 | 2 | |a pubmed24n1335.xml |
035 | |a (DE-627)NLM369804422 | ||
035 | |a (NLM)38490766 | ||
035 | |a (PII)S1521-6926(24)00006-9 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Schmidt, Alexander H |e verfasserin |4 aut | |
245 | 1 | 0 | |a Providing hematopoietic stem cell products from unrelated donors to the world |b DKMS donor centers and DKMS Registry |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 18.03.2024 | ||
500 | |a Date Revised 18.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a Allogeneic hematopoietic stem cell (HSC) transplantation is a curative therapy for many severe blood diseases. As many patients have no suitable family donor, large unrelated donor registries and donor centers have been established in many countries, along with an international system for the provision of unrelated donor HSC products. As an essential part of this system, DKMS operates donor centers in 7 countries with a total of 12.2 million donors and over 114,000 donations so far, and a multinational donor registry. In 2022, DKMS donors contributed 57.5% of all cross-border donations worldwide. In this review, we describe the international system for the provision of unrelated donor HSC products as well as tasks and responsibilities of donor registries and donor centers. We also discuss relevant aspects of DKMS donor centers, namely donor file composition, matching and donation probabilities and actual donations, and the unique multinational approach of the DKMS Registry | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a DKMS | |
650 | 4 | |a Donor center | |
650 | 4 | |a Donor registry | |
650 | 4 | |a Hematopoietic stem cell transplantation | |
650 | 4 | |a WMDA | |
700 | 1 | |a Sauter, Jürgen |e verfasserin |4 aut | |
700 | 1 | |a Schetelig, Johannes |e verfasserin |4 aut | |
700 | 1 | |a Neujahr, Elke |e verfasserin |4 aut | |
700 | 1 | |a Pingel, Julia |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Best practice & research. Clinical haematology |d 2001 |g 37(2024), 1 vom: 15. März, Seite 101541 |w (DE-627)NLM112621287 |x 1532-1924 |7 nnns |
773 | 1 | 8 | |g volume:37 |g year:2024 |g number:1 |g day:15 |g month:03 |g pages:101541 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.beha.2024.101541 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 37 |j 2024 |e 1 |b 15 |c 03 |h 101541 |